Patients with platinum-sensitive recurrent ovarian cancer, regardless of their BRCA mutation status, showed extended progression-free survival with the new PARP inhibitor niraparib.
Medscape Medical News …read more
Miami OBGYN Society
A Membership Organization of South Florida Obstetrician-Gynecologists
